Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
𝛼
SK
or Search
SIGN UP
SIGN IN
ENTITY
Taisho Pharmaceutical Holdin (4581 JP)
Watchlist
78
Analysis
Health Care
•
Japan
Taisho Pharmaceutical Holdings Company Ltd. produces and sells pharmaceuticals, foods, and other related products. The Company also provides insurance agency and information processing services and operates hotel businesses.
more
Watchlist
All
Insights
Primers
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
JSR Corp
•
02 Apr 2024 16:51
JSR Corporation (4185 JP): Murakami Becomes a Substantial Shareholder
Murakami's disclosure suggests two possibilities: starting an activist campaign for a bump or pursuing the appraisal process to determine a fair...
Arun George
Follow
685 Views
Share
bullish
•
Lawson Inc
•
27 Mar 2024 17:41
Lawson (2651 JP): KDDI Corp (9433 JP) Tender Offer Launches
On balance, the offer will likely succeed. At the last close and for a 7 May payment, the gross and annualised spread is 0.5% and 5.4%, respectively.
Arun George
Follow
543 Views
Share
bullish
•
Benefit One Inc
•
31 Jan 2024 11:55
(Mostly) Asia M&A, Jan 2024: Newmark, Eureka, Aoki, Medley, Payroll, Kerry Express, Genetron, TDCX
For the month of January 2024, 8 new transactions (firm and non-binding) were discussed on Smartkarma with an overall announced deal size of...
David Blennerhassett
Follow
504 Views
Share
bullish
•
Benefit One Inc
•
21 Jan 2024 07:00
Last Week in Event SPACE: Benefit One, China Unicom, Zhejiang Expressway/ Zheshang Sec, Hollysys
The weekend is here! Pour yourself a coffee, grab a comfortable seat, and sift through a brief summary of insights on various events discussed...
David Blennerhassett
Follow
621 Views
Share
bullish
•
Weiqiao Textile
•
20 Jan 2024 20:00
(Mostly) Asia-Pac Weekly Risk Arb Wrap: Genetron, Guppy, Weiqiao Textile, Taisho Pharma, T&K Toka
This insight provides a summary of gross/annualised spreads (on deals discussed on Smartkarma) across Asia-Pacific as at the last trading date, and...
David Blennerhassett
Follow
730 Views
Share
First
Previous
3
4
5
6
7
8
9
Next
Last
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
How Smartkarma Compares
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4
x